Finnish study maps the Real-World journey of advanced prostate cancer
NCT ID NCT05701007
Summary
This study looked back at the medical records of over 1,000 men in Finland with advanced prostate cancer that had spread. Its goal was to understand who gets this disease, what treatments they receive, and how well those treatments work in everyday practice. By analyzing this real-world data, researchers aim to improve future care and understand the full impact of the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION SENSITIVE PROSTATE CANCER (MCSPC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
Helsinki, Finland
Conditions
Explore the condition pages connected to this study.